Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06745063
PHASE2
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
Sponsor: VA Office of Research and Development
View on ClinicalTrials.gov
Summary
The study will assign participants to take either the medication, empagliflozin or a placebo for 12 weeks. The goal of the study is to determine the effects of empagliflozin on arterial health in Veterans with obesity.
Key Details
Gender
All
Age Range
30 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-05-30
Completion Date
2029-12-31
Last Updated
2025-11-14
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Empagliflozin
12 week treatment with 10mg empagliflozin daily
DRUG
Placebo
12 week treatment with 10mg placebo daily
Locations (1)
Harry S. Truman Memorial, Columbia, MO
Columbia, Missouri, United States